Bladder Cancer

The impact of perivesical lymph node metastasis on clinical outcomes of bladder cancer patients undergoing radical cystectomy. August 23, 2019

Comparative Effectiveness of Treatment Strategies for Squamous Cell Carcinoma of the Bladder. August 23, 2019

Assessing the Impact of Time to Cystectomy for Variant Histology of Urothelial Bladder Cancer. August 22, 2019

Propensity-matched analysis of stage-specific efficacy of adjuvant chemotherapy for bladder cancer. August 22, 2019

Checkpoints inhibitors in the (neo)adjuvant setting of solid tumors: lessons learnt and perspectives. August 22, 2019

Development and Validation of an Improved Pathological Nodal Staging System for Urothelial Carcinoma of the Bladder. August 21, 2019

Discerning Patterns and Quality of Neoadjuvant Chemotherapy Use Among Patients with Muscle-invasive Bladder Cancer. August 21, 2019

Incidence, Patterns, and Outcomes with Adjuvant Chemotherapy for Residual Disease After Neoadjuvant Chemotherapy in Muscle-invasive Urinary Tract Cancers. August 21, 2019

Current advances in BCG-unresponsive non-muscle invasive bladder cancer. August 20, 2019

Cost-effectiveness of Pembrolizumab as Second-line Therapy for the Treatment of Locally Advanced or Metastatic Urothelial Carcinoma in Sweden. August 20, 2019

A review on the accuracy of bladder cancer detection methods. August 20, 2019

Predictive Factors for Residual Cancer in Second Transurethral Resection for Non-muscle-invasive Bladder Cancer. August 19, 2019

The Impact of Radiotherapy Facility Volume on the Survival and Guideline Concordance of Patients With Muscle-invasive Bladder Cancer Receiving Bladder-preservation Therapy. August 19, 2019

Organ preservation in bladder cancer: an opportunity for truly personalized treatment. August 19, 2019

APOBEC Mutagenesis is Associated with FGFR3 S249C Mutations in Bladder Cancer - Expert Commentary August 16, 2019

Recurrence Risk Prediction Nomogram for Non-muscle Invasive Bladder Cancer Patients - Expert Commentary August 16, 2019

Early Detection of Relapse using Circulating Tumor DNA in Patients with Urothelial Bladder Carcinoma – Expert Commentary August 16, 2019

Conditional Reprogramming of Patient-derived Bladder Cancer Cells for Personalized Treatment Strategies – Expert Commentary August 16, 2019

Phase II California Cancer Consortium Trial of Gemcitabine-Eribulin Combination in Cisplatin-Ineligible Patients With Metastatic Urothelial Carcinoma: Final Report (NCI-9653). August 16, 2019

Viral targeting of non-muscle invasive bladder cancer and priming of anti-tumour immunity following intravesical Coxsackievirus A21. August 16, 2019

Page 1 of 301

E-Newsletters

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.